You just read:

CHMP Announces Positive Opinion for REZOLSTA™, a New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir and Cobicistat

News provided by

Janssen-Cilag International NV

29 Sep, 2014, 07:23 BST